Skip to main content

Laryngectomy

0
Pipeline Programs
1
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Atos Medical
Atos MedicalSweden - Horby
4 programs
Provox LifeN/A1 trial
Provox Life Comfort AdhesiveN/A1 trial
Provox Life Heat and Moisture ExchangerN/A
Voice ProsthesisN/A4 trials
Active Trials
NCT04974801Completed40Est. Apr 2021
NCT07366281Not Yet Recruiting25Est. Apr 2027
NCT05079386Completed17Est. Jan 2023
+3 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Atos MedicalVoice Prosthesis
Atos MedicalVoice Prosthesis
Atos MedicalProvox Life Comfort Adhesive
Atos MedicalVoice Prosthesis
Atos MedicalProvox Life
Atos MedicalVoice Prosthesis

Clinical Trials (6)

Total enrollment: 156 patients across 6 trials

NCT00884910Atos MedicalVoice Prosthesis

Long Term Use of the Provox Vega 22.5

Start: Feb 2008Est. completion: Mar 201033 patients
Phase 2Completed
NCT00743262Atos MedicalVoice Prosthesis

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Start: Apr 2008Est. completion: Apr 200915 patients
Phase 1/2Completed
NCT07366281Atos MedicalProvox Life Comfort Adhesive

Post-operative Use of New Adhesive After Total Laryngectomy

Start: Mar 2026Est. completion: Apr 202725 patients
N/ANot Yet Recruiting
NCT05079386Atos MedicalVoice Prosthesis

Clinical Feasibility of a New Voice Prosthesis

Start: Jan 2022Est. completion: Jan 202317 patients
N/ACompleted

Assessment of the New Provox Life System for Pulmonary Health and Quality of Life After Total Laryngectomy

Start: Dec 2020Est. completion: Apr 202140 patients
N/ACompleted
NCT00661570Atos MedicalVoice Prosthesis

Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis

Start: Mar 2008Est. completion: Mar 200926 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.